AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $56,525 | -74.8% | 78,736 | -20.4% | 0.00% | – |
| Q4 2021 | $224,000 | -24.3% | 98,948 | -3.8% | 0.00% | – |
| Q3 2021 | $296,000 | -17.8% | 102,890 | +8.4% | 0.00% | – |
| Q2 2021 | $360,000 | +20.0% | 94,950 | +7.1% | 0.00% | – |
| Q1 2021 | $300,000 | +18.6% | 88,665 | -2.0% | 0.00% | – |
| Q4 2020 | $253,000 | +24.0% | 90,451 | +11.2% | 0.00% | – |
| Q3 2020 | $204,000 | -79.3% | 81,345 | +5.0% | 0.00% | -100.0% |
| Q2 2020 | $984,000 | +71.1% | 77,476 | +2.1% | 0.00% | 0.0% |
| Q1 2020 | $575,000 | +26.4% | 75,862 | +5.5% | 0.00% | – |
| Q4 2019 | $455,000 | +47.2% | 71,929 | -4.0% | 0.00% | – |
| Q3 2019 | $309,000 | -14.9% | 74,931 | 0.0% | 0.00% | – |
| Q2 2019 | $363,000 | -23.1% | 74,931 | +29.9% | 0.00% | -100.0% |
| Q1 2019 | $472,000 | +53.2% | 57,669 | +3.6% | 0.00% | – |
| Q4 2018 | $308,000 | -0.3% | 55,678 | +59.0% | 0.00% | – |
| Q3 2018 | $309,000 | -22.6% | 35,024 | -12.3% | 0.00% | – |
| Q2 2018 | $399,000 | +22.0% | 39,941 | +16.4% | 0.00% | – |
| Q1 2018 | $327,000 | -36.6% | 34,321 | -1.2% | 0.00% | -100.0% |
| Q4 2017 | $516,000 | -24.2% | 34,725 | +0.3% | 0.00% | 0.0% |
| Q3 2017 | $681,000 | +59.5% | 34,632 | +16.5% | 0.00% | 0.0% |
| Q2 2017 | $427,000 | +53.0% | 29,728 | -2.1% | 0.00% | – |
| Q1 2017 | $279,000 | -0.7% | 30,379 | +12.4% | 0.00% | – |
| Q4 2016 | $281,000 | +17.6% | 27,035 | +2.4% | 0.00% | – |
| Q3 2016 | $239,000 | +21.9% | 26,406 | +0.4% | 0.00% | – |
| Q2 2016 | $196,000 | +14.0% | 26,289 | +36.3% | 0.00% | – |
| Q1 2016 | $172,000 | -23.9% | 19,289 | +10.2% | 0.00% | – |
| Q4 2015 | $226,000 | +32.9% | 17,499 | 0.0% | 0.00% | – |
| Q3 2015 | $170,000 | -5.0% | 17,499 | +0.6% | 0.00% | – |
| Q2 2015 | $179,000 | +713.6% | 17,391 | +787.7% | 0.00% | – |
| Q1 2015 | $22,000 | +22.2% | 1,959 | +22.9% | 0.00% | – |
| Q4 2014 | $18,000 | -85.6% | 1,594 | -71.6% | 0.00% | – |
| Q3 2014 | $125,000 | -13.2% | 5,616 | +8.5% | 0.00% | – |
| Q2 2014 | $144,000 | – | 5,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |